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ABSTRACT: Numerous metabolic proﬁling pipelines have been developed to
characterize the composition of human bioﬂuids and tissues, the vast majority of
these being for studies in adults. To accommodate limited sample volume and to
take into account the compositional diﬀerences between adult and infant bioﬂuids,
we developed and optimized sample handling and analytical procedures for
studying urine from newborns. A robust pipeline for metabolic proﬁling using
NMR spectroscopy was established, encompassing sample collection, preparation,
spectroscopic measurement, and computational analysis. Longitudinal samples
were collected from ﬁve infants from birth until 14 months of age. Methods of
extraction and eﬀects of freezing and sample dilution were assessed, and urinary
contaminants from breakdown of polymers in a range of diapers and cotton wool
balls were identiﬁed and compared, including propylene glycol, acrylic acid, and
tert-butanol. Finally, assessment of urinary proﬁles obtained over the ﬁrst few
weeks of life revealed a dramatic change in composition, with concentrations of
phenols, amino acids, and betaine altering systematically over the ﬁrst few months of life. Therefore, neonatal samples require
more stringent standardization of experimental design, sample handling, and analysis compared to that of adult samples to
accommodate the variability and limited sample volume.
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■ INTRODUCTION
The early life environment has been shown to exert a long-
reaching impact on childhood and later life health. Mode of
birth, feeding, and drug exposure have all been associated with
disease risk, including asthma and allergy in childhood and
metabolic syndrome and cardiovascular disease in later life.7
Metabolic phenotyping of bioﬂuids using high resolution
spectroscopic techniques can be used to eﬀectively characterize
physiological or pathological processes with the aim of
biomarker identiﬁcation or augmenting mechanistic under-
standing of biology.1−4 Collection and analysis of infant
bioﬂuids imposes an analytical challenge because, in contrast
to adult samples, sample volumes are typically smaller. Urine
samples are collected from neonates using plastic collection
bags secured to the infant with adhesive or, more commonly,
disposable diapers with sterile cotton balls or pads inside the
diaper,18−20 because the adhesive bags can cause skin irritation.
Metabolic analysis of urine collected directly onto cotton wool
or diapers can cause the introduction of contaminants from
both the diaper and the cotton ball, and the sample can also be
contaminated by fecal material.21−25,34
The clinical potential of metabonomics in neonatology is
evidenced by a growing body of publications, demonstrating
how physiological fetal development or pathological conditions
aﬀect perinatal and neonatal outcomes.7−10 In addition to
providing a detailed phenotype of acute infant illnesses,
metabolic proﬁling can provide a baseline template for
understanding downstream health. For this reason, there is an
increasing interest in establishing a phenotypic database of
postnatal maturation and development of newborns. The
literature relating to the biochemical composition of bioﬂuids in
neonates is relatively sparse with little known of the normal
metabolic trajectory of the healthy neonate.11 Growth,
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gestational age, nutritional composition of breast milk, and
infection have been shown to inﬂuence the metabolic
composition of urine and plasma.12−15
Thus far, metabonomic approaches have been used in
experimental neonatology to shed light on conditions such as
inborn errors of metabolism, cardiovascular, renal, and
respiratory diseases, postnatal hypoxia/asphyxia, systemic
infections (e.g., neonatal sepsis), brain injury, necrotizing
enterocolitis, investigation of short- and long-term eﬀects of
prematurity, low birth weight, and mode of delivery as well as
stratiﬁcation of infants into risk groups according to response to
various pharmacological treatments, such as gastroesophageal
reﬂux treatments. However, sample collection and analysis
methods have not been standardized, and the studies to date
have used diﬀerent sample collection procedures, analytical
platforms, and data modeling strategies.5−7,9,11,13−17
We present a systematic assessment of sample collection,
processing, and spectral analysis of urine samples from limited
volume samples applied to newborn infants to characterize the
changes in metabolic phenotype over the ﬁrst few weeks of life
and to address the challenge of sample limitations and potential
contamination from external sources. We propose an optimized
analytical pipeline for NMR spectroscopic analysis of infant
urine to ensure robust data generation and to facilitate
interlaboratory comparison of data sets.
■ MATERIALS
We developed and applied a sample collection and analysis
pipeline for infant urine samples as deﬁned in Figure 1. Urine
collection was based around extraction of urine directly from
cotton wool balls or onto cotton wool pads inserted into
diapers because clean catch urine, which is standard for adult
collection, is diﬃcult to obtain from infants. Contaminants
derived from the collection materials introduced were
characterized in the urine metabolic proﬁle. Urine samples
were collected from infants born at term as part of an ongoing
study at the Chelsea and Westminster Hospital. Research
Ethics Committee approval was obtained from the West
London Research Ethics Committee (REC reference number
12/LO/0203 and 10/H0/7135)
Extraction of Urine from Cotton Balls
A volume of 3 mL of urine was added onto cotton wool and
incubated for 2 h at 37 °C (to mimic the typical infant urine
collection conditions). Urine was extracted from the cotton
wool in the following ways: (1) urine-ﬁlled cotton wool was
frozen overnight at −80 °C prior to extraction, (2) extracted
directly from the cotton wool immediately after collection and
frozen overnight at −80 °C, (3) extracted directly from the
cotton wool immediately after collection, and (4) as a fresh
clean catch urine sample. Extraction from the cotton wool was
carried out in two ways to assess whether chemical
contamination originated from exposure to laboratory equip-
ment: (1) squeezed from the cotton wool into a falcon tube or
(2) extracted into a falcon tube by centrifugation. Extraction by
centrifugation involved adding the cotton wool to a falcon tube
and positioning an open ended plastic tube (a cryo-tube cut
into a cylindrical shape, Figure S1) underneath it to stop the
cotton wool from moving to the bottom of the tube to ensure
that as much urine as possible was extracted. Diapers were also
processed using a similar method. Urine was added to cotton
wool, and this was placed into the diﬀerent diapers and
incubated at 37 °C for 2 h after which urine was extracted by
manually squeezing the cotton wool. For NMR analysis, 540 μL
of urine was transferred to 5 mm NMR tubes and 60 μL of
phosphate buﬀer (potassium dihydrogen phosphate (KH2PO4),
3-trimethylsilyl propionic acid-d4 acid sodium salt (TSP),
sodium azide (NaN3), and potassium hydroxide solution (KOH
45% w/w), Sigma-Aldrich, Gilliingham, UK) was added. In
addition to urine, water was used to obtain an experimental
blank sample from both cotton wool and diapers to identify
potential chemicals leaching from the collection materials.
Acquisition of 1H NMR Spectral Proﬁles of Urine and Blank
Samples
All 1H NMR spectra were acquired on a Bruker DRX-600
spectrometer (Bruker Biospin, Karlsruhe, Germany) operating
at 600.29 MHz for proton observation using a standard one-
Figure 1. Schematic pipeline development for metabolic proﬁling of infant urine.
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dimensional water presaturation pulse sequence [relaxation
delay, 90°, t1, 90°, tm, 90°, acquire free-induction decay (FID)].
The relaxation delay was 4 s followed by application of a 90°
radio frequency pulse; t1 (the interpulse delay) was set to 3 μs,
and tm is the mixing time of 100 ms. The probe was matched
and tuned automatically to the proton transmitter resonance
frequency before acquisition for each sample. Samples were run
at a temperature of 300 K.
Figure 2. (a) 1D 1H NMR water blank spectra from cotton wool (red spectrum) and diaper blanks (green spectrum). Key: 1, isobutyl alcohol (δ
0.88 −CH3); 2, propylene glycol (δ 1.14 −CH3, 3.43 −CH2, 3.53 −CH2, 3.87 −CH); 3, tert-butanol (δ 1.25 −CH3); 4, acetate (δ 1.92 −CH3); 5,
N,N-dimethylacetamide (δ 2.1 −CH3, δ 2.9 −CH3, δ 3.1 −CH3); 6, acetone (δ 2.23 −CH3); 7. acrylic acid (δ 5.76 − CH, 6.02 −CH, 6.11 −CH); 8,
unknown metabolite (δ 6.02); 9, formate (δ 8.46 −CH); 10, ethylene glycol (δ 3.7 −CH); 11, propionate (δ 2.19 −CH2, 1.06 −CH3). (b) 2D
COSY 1H NMR spectra, dotted line depicting propylene glycol (δ 1.14 −CH3, 3.43 −CH2, 3.87 −CH). (c) 1D 1H NMR partial urine spectra (δ
1.85−2.75) from cotton wool that was subjected to freeze−thaw cycles: (i) urine extracted from cotton wool and then subjected to one freeze thaw
cycle; (ii) urine extracted from cotton wool after one freeze thaw cycle; (iii) urine extracted from cotton wool and acquired immediately; and (iv)
control blank urine. Key: 1, acetate (δ 1.92 −CH3); 2, acetone (δ 2.23 −CH3); 3, citrate (δ 2.55 −CH2, δ 2.66 −CH2); 4, dimethylamine (δ 2.72
−CH3).
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Spectral preprocessing and preliminary comparisons of the
spectra were performed using the Bruker TopSpin 3.1 program.
Multivariate statistical modeling was performed using Math-
works Matlab R2014a (The Mathworks Inc., USA) and
Umetrics SIMCAP 14.0 (Umetrics, Sweden).
Characterization of Chemical Contamination from
Collection Materials
For contamination of an infant urine metabolic proﬁle to be
assessed, diﬀerent diapers and cotton wool brands were
investigated. Three brands of diapers were assessed; for the
purpose of brevity, these brands will be regarded as diaper
brand 1 (Pampers), diaper brand 2 (UK hospital brand Libero),
and diaper brand 3 (UK store brand Tesco). Four cotton wool
brands were also assessed; three UK store brands (Tesco,
Sainsbury’s, and Boots) and UK hospital brand (Robinson’s
Healthcare). Because the capacity of urine and water as solvents
may be diﬀerent, the collection materials were assessed using
H2O as a blank sample as well as a pooled infant urine sample
from infants at postpartum ages from 0 to 19 weeks. An aliquot
of 3 mL of a quality control infant urine sample was transferred
onto four diﬀerent brands of cotton wool ball (Sainsbury’s,
Tesco, Boots, and Robinson’s Healthcare) and also onto the
three diﬀerent diapers (Pampers, Tesco, and Libero) combined
with the cotton wool. Samples were analyzed using 1H NMR
spectroscopy.
Assessment of Dilution Factor and Spectral Normalization
on Infant Urine Proﬁles
Biosamples collected from infants are often limited in amount
compared with adults; this is especially true for preterm infants
who in addition to producing smaller volume of urine than
equivalent term babies often have other underlying conditions.
Therefore, as part of the method development for infant
bioﬂuid analysis, the detection limits in terms of obtaining
reproducible urine proﬁles were investigated for metabolic
phenotyping by 1H NMR spectroscopy. Urine was collected
from ﬁve term-born infants in the ﬁrst week postpartum and a
dilution series (original concentration sample, and a dilution
series of 1/2, 1/4, 1/8 of the original concentration, as detailed
in Figure S2) were created for each of the ﬁve samples. To
compensate for the decrease in signal-to-noise in more dilute
samples, the number of scans used to acquire spectral proﬁles
was increased by √n, which in turn increased the duration of
the NMR experiment. The signal-to-noise ratio (S/N) of an
NMR signal is improved by using signaling averaging; the S/N
improves with √n, where n is the number of signals averaged.
NMR data were normalized using the probabilistic quotient
normalization (PQN), which particularly accommodates for
dilution diﬀerences between samples by scaling the spectra to a
median reference spectrum.28 Although the spectra of urine
extracted from cotton wool or directly from diapers contained
contaminants, the data were not remodeled after exclusion of
these resonances because they do not dominate the coeﬃcients
of any model with the exception of the comparison of diﬀerent
cotton wool and diaper brands.
Assessment of Age Variability on Infant Urine Proﬁles
Infants develop rapidly from birth with consequential
adaptation of physiology, which is likely to cause their
metabolic proﬁle to dramatically change in the ﬁrst few
weeks of life. Thus, unlike adults where metabolic phenotypes
are generally stable over narrow age ranges, the time of
sampling may be more important in infant studies. Therefore,
the assessment of age variability on infant proﬁles was
investigated for metabolic phenotyping by 1H NMR spectros-
copy. Urine samples taken for a mother-infant comparison were
obtained from mother-infant dyads (n = 10) using only infants
born at term. Urine samples were taken from the infant at 0, 14
days, 8 weeks, and 14 months postpartum, and a further
maternal sample was taken at the time of birth for comparison.
■ RESULTS AND DISCUSSION
Assessment of Methods for Extracting Urine from Cotton
Wool
The centrifugation apparatus design (Figure S1) allowed
eﬃcient extraction of urine from the cotton wool compared
to that of manual squeezing. In contrast to the study by
Goodpaster and colleagues,25 who reported no chemical
leaching from cotton balls, we found clear evidence of tert-
butanol, isobutyl alcohol, acetone, formate, and acetate leaching
into both the water blank and urine sample blank, which were
extracted from the cotton. The urine sample extracted from the
cotton wool after squeezing had a much higher concentration
of acetone, tert-butanol, and isobutyl alcohol than the urine
obtained via centrifugation, suggesting that manual squeezing of
cotton wool results in greater destruction of the cotton wool
ﬁbers and therefore greater release of contaminants into the
urine sample. This further underscores the need for well-
deﬁned standard operating procedures and materials, and
although beyond the scope of the current study, it raises the
question as to whether exposure of infants to these chemicals
has any health-related consequences.
We further assessed the eﬀect of freezing the urine sample, in
the cotton wool prior to extraction as well as frozen after
extraction, and compared this with urine obtained fresh from a
cotton wool ball and found that there were no obvious
diﬀerences in the level of chemical contamination or
endogenous metabolite proﬁle. Therefore, we ﬁnd freezing
the urine containing cotton wool directly after collection at −80
°C (which is generally more practical than performing
immediate extraction of the urine) to be an acceptable practice.
Furthermore, despite the introduction of contaminants from
the cotton wool, the urine proﬁles were highly similar, and a
change in citrate concentration was the only visual diﬀerence in
the endogenous compound concentration after urine had been
extracted from the cotton wool, which suggests that citrate may
be partially retained in the cotton wool. Furthermore, the
citrate signals (δ 2.55 −CH2; δ 2.66 −CH2) became broader
after treatment with cotton wool, which also suggests that there
was binding of this metabolite (Figure 2(c)).
Characterization of Chemical Contamination from
Collection Materials
As expected, we found that sample collection, preparation, and
acquisition parameters had a strong eﬀect on spectral
composition and that the limitation of sample volume,
constraints of sample collection, and the temporal variation in
bioﬂuid composition in the newborn infant introduced greater
chemical variation than would typically be found in adults.
Therefore, it is essential to standardize methodological
protocols as much as possible. On the basis of the results of
this study, we present some recommendations based on the
experimental practice.
Clean catch urine is diﬃcult to obtain from infants and thus
typical collection means include placing adhesive sample
collection bags on the infants or, more practically, relying on
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extracting urine directly from the diaper or from cotton wool
balls placed inside the diaper. Both cotton wool and diapers
contain chemical contaminants that contribute to the urinary
metabolic proﬁle. NMR easily detects these contaminants
within the urine sample. It is therefore necessary to recognize
these contaminants so that their signals can be excluded from
statistical modeling, which aims to evaluate physiological or
pathological processes. As expected, normalization to the
median spectrum (Figure 3c) ameliorated the variation caused
by diﬀerential dilution and contamination from collection
material, but there is potential for a strong bias to be introduced
if spectra are normalized to total intensity.
Visual comparison of the NMR spectra obtained from blank,
original urine samples and cotton wool-extracted urine samples
were assessed for chemical contaminants (Figure 2a). From
cotton wool, major contaminants were identiﬁed as acetate (δ
1.92 −CH3), acetone (δ 2.23 −H3), formate (δ 8.46 −CH),
citrate (δ 2.55 −CH2, 2.66 −CH2), propylene glycol (δ 1.14
−CH3, 3.43 −CH, 3.54 −CH, 3.87 −CH2), tert-butanol (δ 1.25
−CH3), and isobutyl alcohol (δ 0.88 −CH3) as well as an as yet
unidentiﬁed peak at δ 6.02.
Diﬀerent cotton wool brands contained variable concen-
trations of these metabolites, but the qualitative presence of the
metabolites was consistent. Contaminants from diapers
included propylene glycol (δ 1.14 −CH3, 3.4 −CH, 3.6
−CH, 3.9 −CH2), N,N-dimethylacetamide (δ 2.1 −CH3, 2.9
−CH3, 3.1 −CH3), ethylene glycol (δ 3.7 −CH), tert-butanol
(δ 1.25 −CH3), and isobutyl alcohol (δ 0.88 −CH3) as well as
Figure 3. (a) 1D 1H NMR spectra from one infant with a dilution series in eﬀect with volumes of (i) 540, (ii) 270, (iii) 135, and (iv) 68 μL. (b) PCA
of dilution series: R2(X) = 0.985 (ﬁrst component accounts for 84% of the total variance); Q2 (cum.) = 0.941. (c) PCA of normalized diluted infant
samples: R2(X) = 0.5 (ﬁrst component accounts for 32% of the total variance); Q2 (cum.) = 0.29. Colors represent dilution series of (blue) 540,
(red) 270, (green) 135, and (purple) 68 μL. Diﬀerent shapes represent individual infants.
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acrylic acid (δ 5.76 −CH2, 6.02 −CH2, 6.11 −CH) and
propionate (δ 2.19 −CH2, 1.06 −CH3). A diaper’s absorbent
core is predominantly derived from polymers made from very
small particles of acrylic acid derivatives, giving it its highly
absorbent properties. Our results would suggest that the
observed contaminants are introduced either during the
manufacturing process or that degradation of this polymer
may have occurred, which would argue for further investigation
of the eﬀect of shelf life or storage on the chemicals that leach
from diapers.
Although some of these contaminants, such as polyethylene
glycol in diapers25 and propylene glycol in infant urine, have
been previously reported and associated with baby wipes,34 to
our knowledge we provide here the most comprehensive
assignment of exogenous chemicals deriving from collection
procedures. A systematic analysis of the eﬀect of diﬀerent
diapers on synthetic urine by Goodpaster and colleagues
showed that multivariate analysis of either NMR or LC−MS
spectra resulted in clustering of spectra according to the brand
of diaper, which is consistent with our results (Figure S3). In
Goodpaster’s study, it was estimated that up to 59% of the
NMR spectrum was inﬂuenced by chemical contamination
from diapers. Thus, it is important that the brand of diaper is
standardized across a study to prevent the introduction of
extraneous variation.
Assessment of Dilution Factor and Spectral Normalization
on Infant Urine Proﬁles
Because urine sample dilution can vary greatly, the systematic
eﬀect of dilution on the spectral proﬁle was assessed. The NMR
spectra obtained from an individual sample with each spectrum
Figure 4. Mother−baby urine-matched 1D 1H NMR spectra showing the age variability from birth to 14 months postpartum for (a) mother, (b)
birth, (c) 2 weeks, (d) 8 weeks, and (e) 14 months. Key: 1, valine (δ 0.99 −CH3, 1.04 −CH3); 2, lactate (δ 1.33 −CH3, 4.11 −CH); 3, alanine (δ
1.47 −CH3); 4, acetate (δ 1.92 −CH3); 5, uromodulin (δ 2.06 −CH2); 6, succinate (δ 2.42 −CH2); 7, phenylacetylglutamine (PAG) (δ 2.14 −CH2,
2.46 −CH2, 3.77 −CH2, 7.35 (−CH)3; 8, citrate (δ 2.55 −CH2, 2.66 −CH); 9, creatine (δ 3.02 −CH3 (overlapped with creatinine), 3.92 −CH2);
10, proline betaine (δ 3.11 −CH3, 3.30 −CH3); 11, trimethylamine-N-oxide (δ 3.25 −CH3); 12, glycine (δ 3.55 −CH2); 13, hippurate (δ 3.95
−CH); 14, N-methylnicotinamide (δ 4.48 −CH); 15, fumarate (δ 6.53 −CH3); 16, urocanic acid (δ 6.65); 17, formate (δ 8.45 −CH); 18, propylene
glycol (δ 1.14 −CH3); 19, tert-butanol (δ 1.25 −CH3); 20, acetone (δ 2.24 −CH3); 21, methylguanidine (tentative assignment; δ 2.23 −CH3); 22,
trimethylamine (δ 2.28 −CH3); 23, creatinine (δ 3.05 −CH3, 4.06 −CH2); 24, betaine (δ 3.25 (−CH3)3, 3.89 −CH2); 25, 4-cresol sulfate (δ 2.22
−CH3, 7.11 −CH, 7.18 −CH); 26, 2-oxoglutarate (δ 2.42 −CH); 27, dimethylamine (δ 2.72 −CH3); 28, dimethylglycine (δ 2.93 −CH3); and 29, 3-
methyl-histidine (δ 6.93 −CH, 7.69 −CH).
Journal of Proteome Research Technical Note
DOI: 10.1021/acs.jproteome.6b00234
J. Proteome Res. 2016, 15, 3432−3440
3437
corresponding to a diﬀerent dilution factor, is shown in Figure
3. These results indicate that, after adjustment for the number
of scans to account for diﬀerences in signal-to-noise,30 there
was little visual eﬀect of dilution on the NMR spectral signal
intensities (Figure 3a). However, the dilution factor (indicated
by color) was shown to aﬀect the statistical models obtained
when non-normalized spectra were used, suggesting that
dilution has a physicochemical eﬀect on the observation of
certain metabolite signals, and metabolic diﬀerences between
individuals were more easily observed in the more dilute
samples (indicated by symbols, Figure 3b). Once normalization
was applied to the spectral data, which is typical practice for
metabolic proﬁling studies, using either PQN normalization
with reference to the median spectrum (Figure 3c) or noise
(data not shown) as a standardizing factor, the eﬀect of dilution
was reduced, and clear interindividual diﬀerences between the
infants became apparent at all dilution factors with the
exception of two infants whose proﬁles were largely super-
imposed in the ﬁrst two components (as indicated by the
squares and stars in Figure 3c). This indicates that standard
normalization procedures can largely resolve the eﬀect of
dilution on the spectroscopic proﬁles. For one infant
(represented by diamond symbols), the eﬀect of urinary
dilution was still clearly visible; this infant had the lowest
creatinine to noise ratio, suggesting that the urine sample from
this individual was the most dilute to begin with. A more
accurate way of controlling for diﬀerential concentrations
between samples would be to ensure that all samples were
adjusted for osmolality prior to analysis, but this would require
extra sample and would introduce an extra time constraint and
potential for human error. Because for three of the ﬁve infants
the two most dilute samples were situated to the left of the
corresponding cluster for that individual, we assumed that an
appropriate dilution factor to employ would be no more than
double the original sample volume.
Age Variability in Infant Urine Proﬁles
Given the generally chaotic start to life, it is often diﬃcult to
standardize the exact time of bioﬂuid sampling in infants.
However, this and many previous studies highlight the high
variability in neonatal urine composition in relation to age.
Over the ﬁrst few weeks of life, infant metabolism undergoes
rapid changes, and this is reﬂected in the dynamic urine
proﬁles. Here, we show that urinary NMR spectral proﬁles of
infants at the time of birth (Figure 4b) are evidently very
similar to urinary samples collected from the mother at the
same time (Figure 4a). Throughout pregnancy, the developing
fetus relies on the mother for nutrient uptake, waste removal,
and gas exchange, which occurs through the placenta; thus,
similarities in the global urinary metabolic proﬁle are
observed.32,33 The similarities between mother and newborn
are particularly apparent in the aromatic region of the NMR
spectra. A higher concentration of hippurate and phenyl-
acetylglutamine (PAG) in the infant birth sample can be seen in
comparison to that at later time points. We would expect to see
low concentrations of phenolic and aromatic compounds in
infant urine because these molecules are mainly produced by
gut microbiota. We know from the microbiome literature and
from studies in rodent models that colonization of the infant
gut largely begins at birth, and that over a period of time as the
symbiotic gut bacteria evolve, there is an increase in molecules
such as hippurate, PAG (or the equivalent glycine conjugate in
rodents), indoles, and methylamines.31However, many papers
report an absence of signals in the spectral window of infant
urine where phenolic and other aromatic molecules would be
expected to arise. In the urine sample obtained immediately
postpartum, hippurate, 4-cresylsulfate, and PAG are found in
the infant urine in approximately equivalent concentrations to
the maternal urine. Although there are strong similarities
between mother and newborn infant urine, some diﬀerences
between maternal and infant urine composition are visible at
this initial sampling point, including the presence of higher
concentrations of trimethylamine and formate and lower
concentrations of methylhistidine.
After 2 weeks, the infant’s urine spectrum has become more
dilute compared to that of the mother’s urine (Figure 4c). The
most striking diﬀerence between these spectra is that there is
much less creatinine and almost no hippurate with a reduction
in the excretion of most aromatic compounds in the week 2
sample from the infant compared to that of the birth sample.
This reinforces the observation of products of mother−fetal
exchange of nutrients and waste products in the infant urine
samples obtained immediately postpartum. At this time, betaine
is also found in higher concentrations in the neonatal urine
compared to that in the maternal or later urine samples from
the baby and is thought to reﬂect the as yet immature
kidneys.37
At 14 months (Figure 4d), the infant will have grown
considerably, will be eating more solid foods, and will have a
larger community of bacteria in their gut, which contributes to
metabolism and therefore their urine metabolic proﬁle.35 The
NMR spectra measured at 14 months showed higher
concentrations of creatinine, which is related to muscle mass,
as well as higher levels of metabolites found in the aromatic
region (e.g., hippurate and PAG), which are cometabolites
produced from gut microorganisms.36
Relevance of Results to Neonatal Research
Currently, most clinical tests available in neonatology rely on
technologies that can only measure a single chemical in blood,
urine, or other bioﬂuids; these tests are neither sensitive nor
speciﬁc for any particular disease.26−28 Analysis of the infant
urinary metabolome oﬀers a holistic approach to systems
medicine with the promise to enhance clinical chemistry
diagnostics in several pathologic conditions related to newborns
and signiﬁcantly improve monitoring of physiological develop-
ment and disease.29 The goal is for each condition or disease to
derive a discrete metabolic phenotype, comprised essentially
from small but signiﬁcant diﬀerences in certain metabolites.10
Thus, scientists need to be sure that these discriminant
metabolites are products of a neonate’s metabolism and kidney
function and not just byproducts of the cotton wool and
diapers used to collect the bioﬂuids.
This issue of possible contaminants has been examined and
further reported using NMR-based metabonomics in three
diaper brands using the “diaper plus cotton ball” technique.30
The authors found that the NMR spectra of the two cotton ball
brands examined were identical; thus, only one brand of cotton
ball was used for “diaper plus cotton ball” sample analysis. It
also indicated that, although certain diaper brands are more
likely to exhibit distinct contaminant proﬁles than others, the
contamination levels of newborn urine collected using the
“diaper plus cotton ball” technique generally contain less diaper
contamination than the “diaper alone” technique. Therefore, it
is advised that diapers and cotton balls are chemically
characterized using metabonomic methodologies prior to
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analysis of study urine samples.22 In this way, contaminants
arising from collection material would be manageable, and
unwanted variation introduced by contamination can be
minimized.
Infant age is an important variable that contributes to the
metabolic proﬁle of bioﬂuids, and thus, establishing the
metabolic proﬁles linked to age has become a priority. From
birth, the infant urinary metabolic proﬁle can be related to the
mother and changes dramatically in the ﬁrst few days after
birth. The infant’s body continues to develop outside of the
womb, and as they start to establish a gut microbiome, the
metabolic proﬁle reiterates this through changes in their
metabolome; this is particularly evident over the ﬁrst few days
of life. The knowledge of an age-related metabolic proﬁle can
make the interpretation of data for other eﬀects such as disease
easier, which is important in biomarker discovery for disease
diagnosis or prognosis. In studies where age is not standardized,
this should be appreciated and incorporated into the data
modeling strategy.
Standardization of experimental design and subsequent
analysis is imperative for interpretation of metabolic data
generated in neonatal studies. Improved tools for metabonomic
analysis incorporating a reproducible analytical pipeline for
sample collection, processing, and analysis along with its
integration with other ‘-omics’ (proteomics, epigenomics, etc.)
analysis will make this technology valuable in the clinical
setting, opening new possibilities for disease diagnosis and
assessment of disease risk. In particular, metabolic proﬁling of
neonates will not only impact diagnosis and treatment of
neonatal diseases but may deliver validated biomarkers of early
life stress, which could be used for predicting individual
predisposition to disease or to the monitoring of disease
progression and therapeutic management (Table 1).
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